Name | Deriglidole |
---|---|
Synonyms |
(+)-1,2,4,5-Tetrahydro-2-(2-imidazolin-2-yl)-2-propylpyrrolo(3,2,1-hi)indole
UNII-68EP8R4PMV 2-(4,5-dihydro-1h-imidazol-2-yl)-2-propyl-1,2,4,5-tetrahydropyrrolo[3,2,1-hi]indole |
Description | Deriglidole is a peripheral adrenoceptor antagonist with a high affinity for α2-adrenoceptors. |
---|---|
Related Catalog | |
Target |
Adrenoceptor[1] |
In Vitro | Deriglidole is a selective α2-receptor inhibitor. Deriglidole inhibits [3H]Clonidine and [3H]Idazoxan but not [3H]Prazosin binding to rat cortical and human platelet α2-adrenoceptors and is more selective than Idazoxan for peripheral receptors[1]. |
References |
Density | 1.27g/cm3 |
---|---|
Boiling Point | 456.4ºC at 760mmHg |
Molecular Formula | C16H21N3 |
Molecular Weight | 255.35800 |
Flash Point | 229.8ºC |
Exact Mass | 255.17400 |
PSA | 27.63000 |
LogP | 1.97520 |
Vapour Pressure | 1.62E-08mmHg at 25°C |
Index of Refraction | 1.686 |
Storage condition | 2-8℃ |